BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for contract manufacturing, research, and packaging in the pharmaceuticals industry. The key objective is to present a comprehensive analysis of the current market and its future direction in the pharmaceuticals and biotechnology outsourcing industry with the emphasis on contract manufacturing.
This report explores present and future strategies within the contract manufacturing, research, and packaging pharmaceuticals industry. The needs, services offered, criteria for selection, and the advantages of outsourcing are discussed. The study also includes the need for project management, market forecasts and a discussion of the market leaders in the industry. Regulatory requirements and current state of the outsourcing market in the pharmaceuticals and biotechnology industry are also portrayed in this report.
A detailed analysis of the pharmaceutical-biopharmaceutical contract manufacturing, research, and packaging industry structure has been conducted. Revenues are broken down by bulk as well as by dosage forms of solid, liquid, and semisolid pharmaceuticals. Sales figures are estimated for the 5 year period from 2009 through 2014.
Over-the-counter (OTC), nutritional, and drug-delivery products are discussed separately in this report. Contract research and contract packaging are also discussed separately
REASONS FOR DOING THIS STUDY
Many pharmaceutical companies choose outsourcing as an option, or choice, to better market their products without spending time in drug discovery and the manufacturing process. These pharmaceutical companies rely on contract manufacturers and researchers. This study examines the different types of contracting companies in the pharmaceuticals industry. Rapid development of technologies and major changes in market behavior also justify a focus on this segment.
Several important trends in outsourcing need to be tracked and analyzed. Outsourcing in the pharmaceuticals industry has changed in recent years. The major reason behind the use of contract-manufacturing organizations (CMOs) in the pharmaceuticals industry is the innovative and state-of-the-art process and production technologies CMOs offer. Other reasons to contract an outsourced company are to achieve efficiencies in cost, capacity, time-to-market, and the need to obtain specific expertise not available in-house.
This study contributes to the areas of market growth in pharmaceuticals contract manufacturing, research, and packaging from the point of view of manufacturers and users. Biochemical companies, physicians, the pharmaceuticals and biopharmaceuticals industries, and pharmaceutical research companies will find value in this study.
SCOPE OF THE STUDY
The scope of this study encompasses the contract manufacturing, research, and packaging markets. BCC analyzes each market and its applications by its need for outsourcing, regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.
BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with various analytical, chemical, pharmaceutical, and contracting experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.
Many companies within the industry were surveyed to obtain data for this study. Included were manufacturers and end users of pharmaceuticals through contract manufacturing and research. Data were gathered from various industry sources. BCC spoke with officials and physicians within the industry, and consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.
ABOUT THE AUTHOR
Shalini S. Dewan holds a master’s degree in pharmaceutical chemistry. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest, from ibuprofen and 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are Reagents of Chromatography; Spectroscopy, an Enduring Market; Advanced Drug Delivery Systems; Orthopedic Drugs, Implants and Devices; Imaging Reagents; Regulatory Industry; and Dynamic Sera, Media and Reagents Used in Biotechnology.
BCC ONLINE SERVICES
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
- Examine BCC’s complete catalog of Market Research Reports and place direct orders
- Subscribe to any of BCC’s many industry newsletters
- Read announcements of recently published reports and newly launched newsletters
- Register for BCC’s well-known conferences
- Request additional information on any BCC product
- Take advantage of special offers
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.